Date
Insider
Company
Owned Shares
Shares Traded
Price
Net Total
BUY
4 May 2023GORDON CARL L
Director, 10% Owner
Kinnate Biopharma Inc.
(KNTE)
1,368,339+1577%
1,460,932
$2.80
$4,086,234.50
BUY
4 May 2023ORBIMED ADVISORS LLC
Director, 10% Owner
Kinnate Biopharma Inc.
(KNTE)
1,368,339+1577%
1,460,932
$2.80
$4,086,234.50
BUY
28 Apr 2023ORBIMED ADVISORS LLC
Director, 10% Owner
Kinnate Biopharma Inc.
(KNTE)
794,368+230%
1,405,168
$2.61
$3,673,900.80
BUY
28 Apr 2023GORDON CARL L
Director, 10% Owner
Kinnate Biopharma Inc.
(KNTE)
794,368+230%
1,405,168
$2.61
$3,673,900.80
BUY
11 Mar 2022Williams Richard Thomas
Chief Medical Officer, Officer
Kinnate Biopharma Inc.
(KNTE)
42,333+1714%
40,000
$8.47
$338,850.00
BUY
11 Feb 2022ORBIMED ADVISORS LLC
Director
Kinnate Biopharma Inc.
(KNTE)
3,509,030+5%
195,700
$10.17
$1,989,446.00
BUY
11 Feb 2022GORDON CARL L
Director
Kinnate Biopharma Inc.
(KNTE)
3,509,030+5%
195,700
$10.17
$1,989,446.00
BUY
3 Dec 2020Tananbaum James B.
Director, 10% Owner
Kinnate Biopharma Inc.
(KNTE)
500,000+200%
1,000,000
$20.00
$20,000,000.00
BUY
2 Dec 2020ORBIMED ADVISORS LLC
Director, 10% Owner
Kinnate Biopharma Inc.
(KNTE)
300,000+166%
750,000
$20.00
$15,000,000.00
BUY
2 Dec 2020GORDON CARL L
Director, 10% Owner
Kinnate Biopharma Inc.
(KNTE)
300,000+166%
750,000
$20.00
$15,000,000.00